Sify.com » Topics » Cefdinir capsules
Cefdinir capsules News
US nod for Aurobindo's Cefdinir capsules
Mumbai: Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration to market its 300mg Cefdinir capsules in the US market. The drug falls under the anti-bacterial segment and is a generic equivalent of Abbott Laboratories, 'OMNICEF'. Earlier, the company also received the final approval for 125 mg/5 ml and 250 mg/5 ml oral suspension of this drug from the USFDA. •
Mumbai: Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration to market its 300mg Cefdinir capsules in the US market. The drug falls under the anti-bacterial segment and is a generic equivalent of Abbott Laboratories, 'OMNICEF'. Earlier, the company also received the final approval for 125 mg/5 ml and 250 mg/5 ml oral suspension of this drug from the USFDA. •
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise